Table 3.
Multivariable associations of lifestyle and anthropometric factors with risk of colorectal cancer according to refined subsites in the NHS, NHS2, and HPFS a.
Risk factor | Proximal colon cancer |
Distal colon cancer |
Rectum cancer |
P for overall heterogeneity c | P for linear heterogeneity d | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Cecum | Ascending colon | Transverse colon | Overall | Descending colon | Sigmoid colon | Overall | Rectosigmoid | Rectum | Overall | |||
n=474 | n=633 | n=250 | n=1357 | n=221 | n=750 | n=971 | n=202 | n=528 | n=730 | |||
Smoking | ||||||||||||
Packyears of smoking, per 20 pack-year | ||||||||||||
HR | 1.12 | 1.14 | 1.12 | 1.13 | 1.10 | 1.03 | 1.05 | 1.11 | 1.12 | 1.11 | ||
95% CI | 1.03–1.22 | 1.06–1.22 | 1.00–1.26 | 1.07–1.19 | 0.97–1.25 | 0.96–1.11 | 0.98–1.12 | 0.96–1.27 | 1.03–1.21 | 1.04–1.20 | 0.61 | 0.40 |
Ptrend | 0.01 | 0.0005 | 0.05 | <0.001 | 0.13 | 0.43 | 0.15 | 0.15 | 0.009 | 0.003 | ||
P for heterogeneity within main subsites c | 0.80 | 0.25 | 0.77 | |||||||||
Packyears of smoking before age 30, per 20 pack-year | ||||||||||||
HR | 1.08 | 1.27 | 1.43 | 1.21 | 1.37 | 1.19 | 1.23 | 1.27 | 1.26 | 1.17 | ||
95% CI | 0.81–1.46 | 0.98–1.65 | 0.99–2.07 | 1.01–1.43 | 1.06–2.33 | 0.95–1.49 | 1.00–1.50 | 0.81–1.97 | 0.96–1.64 | 0.93–1.48 | 0.67 | 0.62 |
Ptrend | 0.60 | 0.07 | 0.06 | 0.03 | 0.03 | 0.13 | 0.048 | 0.30 | 0.10 | 0.18 | ||
P for heterogeneity within main subsites c | 0.10 | 0.21 | 0.76 | |||||||||
Alcohol intake, per 14 g/day | ||||||||||||
HR | 0.99 | 1.02 | 1.25 | 1.06 | 1.18 | 1.11 | 1.12 | 1.10 | 1.14 | 1.12 | ||
95% CI | 0.89–1.11 | 0.92–1.13 | 1.11–1.41 | 0.99–1.13 | 1.02–1.37 | 1.02–1.20 | 1.05–1.20 | 0.93–1.30 | 1.04–1.26 | 1.03–1.22 | 0.11 | 0.09 |
Ptrend | 0.91 | 0.71 | <0.001 | 0.10 | 0.02 | 0.01 | 0.001 | 0.27 | 0.008 | 0.01 | ||
P for heterogeneity within main subsites c | 0.02 | 0.32 | 0.66 | |||||||||
BMI, per 5 kg/m2 | ||||||||||||
Men | n=197 | n=143 | n=107 | n=447 | n=70 | n=292 | n=362 | n=68 | n=186 | n=254 | ||
HR | 1.21 | 1.32 | 1.16 | 1.24 | 1.49 | 1.28 | 1.32 | 1.14 | 1.33 | 1.25 | ||
95% CI | 0.97–1.50 | 1.03–1.68 | 0.87–1.55 | 1.08–1.43 | 1.13–1.96 | 1.11–1.49 | 1.16–1.50 | 0.80–1.64 | 1.08–1.63 | 1.05–1.49 | ||
Ptrend | 0.09 | 0.03 | 0.31 | 0.003 | 0.005 | 0.001 | <0.001 | 0.47 | 0.008 | 0.01 | 0.69 | 0.70 |
P for heterogeneity within main subsites c | 0.87 | 0.21 | 0.62 | |||||||||
Women | n=277 | n=490 | n=143 | n=910 | n=151 | n=458 | n=609 | n=134 | n=342 | n=476 | ||
HR | 1.11 | 1.13 | 1.27 | 1.15 | 1.12 | 1.21 | 1.19 | 1.06 | 1.24 | 1.19 | ||
95% CI | 0.97–1.28 | 1.01–1.25 | 1.06–1.52 | 1.06–1.24 | 0.92–1.37 | 1.09–1.35 | 1.09–1.31 | 0.85–1.32 | 1.09–1.40 | 1.07–1.32 | 0.63 | 0.29 |
Ptrend | 0.14 | 0.03 | 0.01 | <0.001 | 0.25 | 0.0003 | <0.001 | 0.59 | <0.001 | 0.002 | ||
P for heterogeneity within main subsites c | 0.68 | 0.33 | 0.22 | |||||||||
BMI at age 18/21, per 5 kg/m2 | ||||||||||||
Men | n=197 | n=143 | n=107 | n=447 | n=70 | n=292 | n=362 | n=68 | n=186 | n=254 | ||
HR | 1.11 | 1.02 | 1.08 | 1.07 | 0.94 | 1.12 | 1.08 | 1.00 | 1.12 | 1.06 | 0.85 | 0.81 |
95% CI | 0.93–1.32 | 0.85–1.22 | 0.86–1.35 | 0.96–1.20 | 0.75–1.18 | 0.98–1.29 | 0.96–1.21 | 0.77–1.30 | 0.94–1.33 | 0.92–1.22 | ||
Ptrend | 0.23 | 0.85 | 0.50 | 0.21 | 0.60 | 0.10 | 0.22 | 0.99 | 0.22 | 0.43 | ||
P for heterogeneity within main subsites c | 0.84 | 0.20 | 0.43 | |||||||||
Women | n=277 | n=490 | n=143 | n=910 | n=151 | n=458 | n=609 | n=134 | n=342 | n=476 | ||
HR | 1.09 | 1.24 | 1.33 | 1.20 | 1.22 | 1.21 | 1.21 | 1.26 | 1.25 | 1.25 | ||
95% CI | 0.90–1.32 | 1.07–1.42 | 1.03–1.71 | 1.09–1.33 | 0.96–1.55 | 1.05–1.40 | 1.07–1.37 | 0.98–1.62 | 1.07–1.47 | 1.09–1.44 | 0.98 | 0.50 |
Ptrend | 0.39 | 0.003 | 0.03 | <0.001 | 0.11 | 0.007 | 0.002 | 0.07 | 0.006 | 0.001 | ||
P for heterogeneity within main subsites c | 0.70 | 0.94 | 0.96 | |||||||||
Waist circumference, per 10 cm | ||||||||||||
Men | n=197 | n=143 | n=107 | n=447 | n=70 | n=292 | n=362 | n=68 | n=186 | n=254 | ||
HR | 1.17 | 1.31 | 1.09 | 1.21 | 1.83 | 1.27 | 1.37 | 1.31 | 1.25 | 1.27 | ||
95% CI | 0.99–1.39 | 1.09–1.57 | 0.86–1.38 | 1.08–1.34 | 1.43–2.33 | 1.12–1.44 | 1.22–1.53 | 1.02–1.69 | 1.04–1.49 | 1.10–1.47 | 0.09 | 0.58 |
Ptrend | 0.06 | 0.004 | 0.47 | <0.001 | <0.001 | <0.001 | <0.001 | 0.04 | 0.02 | 0.001 | ||
P for heterogeneity within main subsites c | 0.44 | 0.004 | 0.89 | |||||||||
Women | n=277 | n=490 | n=143 | n=910 | n=151 | n=458 | n=609 | n=134 | n=342 | n=476 | ||
HR | 0.98 | 1.08 | 1.14 | 1.06 | 1.02 | 1.09 | 1.08 | 1.04 | 1.07 | 1.06 | ||
95% CI | 0.87–1.11 | 0.99–1.18 | 0.97–1.34 | 0.99–1.13 | 0.87–1.21 | 0.99–1.20 | 0.99–1.17 | 0.88–1.23 | 0.96–1.19 | 0.97–1.16 | 0.70 | 0.59 |
Ptrend | 0.72 | 0.08 | 0.10 | 0.08 | 0.79 | 0.07 | 0.08 | 0.62 | 0.24 | 0.22 | ||
P for heterogeneity within main subsites c | 0.26 | 0.54 | 0.69 | |||||||||
Physical activity, per 7.5 MET-hours/week b | ||||||||||||
HR | 0.99 | 1.01 | 0.97 | 0.99 | 0.96 | 0.96 | 0.96 | 0.97 | 0.98 | 0.98 | ||
95% CI | 0.94–1.04 | 0.97–1.06 | 0.90–1.04 | 0.96–1.02 | 0.89–1.03 | 0.93–1.00 | 0.93–1.00 | 0.90–1.05 | 0.93–1.03 | 0.94–1.02 | 0.49 | 0.35 |
Ptrend | 0.58 | 0.63 | 0.35 | 0.65 | 0.25 | 0.07 | 0.04 | 0.43 | 0.42 | 0.31 | ||
P for heterogeneity within main subsites c | 0.96 | 0.76 | 0.43 | |||||||||
Height, per 10 cm | ||||||||||||
HR | 1.14 | 1.25 | 1.23 | 1.20 | 1.20 | 1.10 | 1.12 | 1.21 | 1.27 | 1.25 | ||
95% CI | 0.99–1.31 | 1.10–1.42 | 1.01–1.49 | 1.10–1.30 | 0.97–1.47 | 0.99–1.23 | 1.02–1.24 | 0.97–1.50 | 1.11–1.46 | 1.12–1.40 | 0.60 | 0.77 |
Ptrend | 0.08 | <0.001 | 0.04 | <0.001 | 0.09 | 0.08 | 0.02 | 0.09 | <0.001 | <0.001 | ||
P for heterogeneity within main subsites c | 0.56 | 0.48 | 0.66 |
Age- and cohort-stratified Cox proportional hazards model was used with adjustment for age (continuous), race, height (continuous), family history of colorectal cancer (yes or no), history of lower gastrointestinal endoscopic screening (yes or no), body mass index (continuous), pack-years of smoking (continuous), physical activity (continuous), alcohol intake (continuous), and regular aspirin use (yes or no).
For physical activity, the follow-up started in 1986 in NHS.
Heterogeneity was tested by using meta-regression method with a subsite-specific random effect term as a nominal variable.
Linear heterogeneity was tested by using meta-regression method with a subsite-specific random effect term as an ordinal variable.